Jason N. Butler
Stock Analyst at Citizens
(1.69)
# 3,327
Out of 5,182 analysts
19
Total ratings
31.58%
Success rate
-7.28%
Average return
Main Sectors:
Stocks Rated by Jason N. Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGEN Precigen | Maintains: Market Outperform | $8 → $9 | $3.94 | +128.43% | 2 | Mar 26, 2026 | |
| NSRX Nasus Pharma | Maintains: Market Outperform | $19 → $18 | $2.35 | +665.96% | 1 | Mar 26, 2026 | |
| ESPR Esperion Therapeutics | Maintains: Market Outperform | $4 → $5 | $2.61 | +91.57% | 1 | Mar 13, 2026 | |
| GHRS GH Research | Maintains: Market Outperform | $39 → $42 | $14.57 | +188.26% | 1 | Mar 6, 2026 | |
| ARGX argenx SE | Maintains: Market Outperform | $925 → $944 | $746.75 | +26.41% | 1 | Feb 27, 2026 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Market Outperform | $8 → $10 | $3.54 | +182.49% | 1 | Feb 26, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Market Outperform | $34 → $35 | $22.20 | +57.69% | 3 | Feb 26, 2026 | |
| ACHV Achieve Life Sciences | Initiates: Market Outperform | $19 | $3.23 | +488.24% | 1 | Nov 25, 2025 | |
| RAPP Rapport Therapeutics | Maintains: Market Outperform | $77 → $80 | $33.58 | +138.24% | 1 | Nov 7, 2025 | |
| WULF TeraWulf | Maintains: Market Outperform | $18 → $22 | $14.88 | +47.85% | 1 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $9 → $17 | $3.12 | +444.87% | 1 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $95 → $114 | $118.37 | -3.69% | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $22 | $7.05 | +212.06% | 1 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $78 | $66.73 | +16.89% | 1 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $19 → $18 | $9.40 | +91.49% | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $91 → $78 | $64.49 | +20.95% | 1 | Aug 6, 2025 |
Precigen
Mar 26, 2026
Maintains: Market Outperform
Price Target: $8 → $9
Current: $3.94
Upside: +128.43%
Nasus Pharma
Mar 26, 2026
Maintains: Market Outperform
Price Target: $19 → $18
Current: $2.35
Upside: +665.96%
Esperion Therapeutics
Mar 13, 2026
Maintains: Market Outperform
Price Target: $4 → $5
Current: $2.61
Upside: +91.57%
GH Research
Mar 6, 2026
Maintains: Market Outperform
Price Target: $39 → $42
Current: $14.57
Upside: +188.26%
argenx SE
Feb 27, 2026
Maintains: Market Outperform
Price Target: $925 → $944
Current: $746.75
Upside: +26.41%
Ironwood Pharmaceuticals
Feb 26, 2026
Maintains: Market Outperform
Price Target: $8 → $10
Current: $3.54
Upside: +182.49%
ACADIA Pharmaceuticals
Feb 26, 2026
Maintains: Market Outperform
Price Target: $34 → $35
Current: $22.20
Upside: +57.69%
Achieve Life Sciences
Nov 25, 2025
Initiates: Market Outperform
Price Target: $19
Current: $3.23
Upside: +488.24%
Rapport Therapeutics
Nov 7, 2025
Maintains: Market Outperform
Price Target: $77 → $80
Current: $33.58
Upside: +138.24%
TeraWulf
Oct 29, 2025
Maintains: Market Outperform
Price Target: $18 → $22
Current: $14.88
Upside: +47.85%
Oct 29, 2025
Maintains: Market Outperform
Price Target: $9 → $17
Current: $3.12
Upside: +444.87%
Sep 25, 2025
Maintains: Market Outperform
Price Target: $95 → $114
Current: $118.37
Upside: -3.69%
Sep 9, 2025
Reiterates: Market Outperform
Price Target: $22
Current: $7.05
Upside: +212.06%
Sep 2, 2025
Reiterates: Market Outperform
Price Target: $78
Current: $66.73
Upside: +16.89%
Aug 13, 2025
Maintains: Market Outperform
Price Target: $19 → $18
Current: $9.40
Upside: +91.49%
Aug 6, 2025
Maintains: Market Outperform
Price Target: $91 → $78
Current: $64.49
Upside: +20.95%